Global Health Limited has informed the Exchange about Resignation of Director/KMP/SMP

Global Health Limited (Medanta) reported strong FY26 results with consolidated revenue of Rs 44,103 million (up 19.4% YoY) and PAT of Rs 5,541 million (up 15.1% YoY). The Board approved an unmodified audit report and recommended a final dividend of Rs 0.50 per share (25% on face value Rs 2). Two new SMPs were appointed: Mr. Kedar Ashok Apte as Chief Marketing & Growth Officer and Mr. Jagdeep Singh as General Counsel, both effective May 14, 2026. Ms. Richa Singh resigned as SMP effective May 20, 2026. The company also announced plans to build a 400-bed hospital in Varanasi via a built-to-suit lease and signed a Business Transfer Agreement for a 79-bed oncology hospital in Indore.